Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM93MAX)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
15264-63-8; 5-(4-Pyridyl)-1,3,4-oxadiazole-2-thiol; 5-(pyridin-4-yl)-1,3,4-oxadiazole-2-thiol; 5-pyridin-4-yl-[1,3,4]oxadiazole-2-thiol; 5-(pyridin-4-yl)-1,3,4-oxadiazole-2(3H)-thione; CHEMBL571513; 5-pyridin-4-yl-1,3,4-oxadiazole-2-thiol; 5-(4-pyridinyl)-1,3,4-oxadiazole-2-thiol; TXCXZVFDWQYTIC-UHFFFAOYSA-N; 1,3,4-Oxadiazole-2(3H)-thione,5-(4-pyridinyl)-; 1,3,4-Oxadiazole-2-thiol, 5-(4-pyridinyl)-; ZERO/005315; AC1LGNJA; ChemDiv2_000174; AC1Q7F3J; Oprea1_812023; Oprea1_290121; SCHEMBL987340; SCHEMBL17065364; CTK4C7526
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||